Experts Advancing Cell-Based Therapeutics
Guided by industry veterans and clinical experts committed to patient outcomes.
Management
Dr. Narayanan 'Suri' Surendran Founder & CSO
Suri has a B. Pharm (Hons) from BITS Pilani, India, and a PhD in pharmaceutical sciences from the University of Arizona, Tucson. He has over 24 years of experience in drug discovery and development with 3 patents, 20+ publications, and 40+ presentations at various scientific conferences. He is the inventor of the granted US patent on the technology being developed by Ayma Therapeutics. His primary area of expertise is drug metabolism and pharmacokinetics (DMPK). He is also the founder of RythRx Therapeutics LLC, an Ann Arbor-based company focused on improving blood and platelet storage.
Ramesh Gopalan Co-Founder, CEO/CTO
Mr. Ramesh Gopalan is also the founder president of Cognitive Mantra Inc. He has over 20 years of experience in delivering enterprise technology solutions. He is currently focused on developing advanced AI and cognitive computing solutions for the pharma and life sciences industry.
Dr. Qais Abu AliChief Medical Officer
Dr. Abu Ali, MD, FACMG is a board-certified geneticist-physician, with over 20 years of experience in clinical practice, molecular diagnostics, clinical trials, and drug development. In 2020, he joined Ayma Therapeutics executive team as the chief medical officer.
Robert DickeyChief Financial Officer/Advisor
Rob Dickey is the managing director at Foresite Advisors, a financial advisory firm for life science companies. He has more than 25 years of experience, primarily as a CFO or a board member, leading life science and medical device companies, both private and public, ranging from early-stage development to commercial operations. Prior to becoming an advisor, he served as a full-time CFO for multiple companies, and before that, he spent 18 years in investment banking, mostly at Lehman Brothers. Rob holds an AB from Princeton University and an MBA from The Wharton School, University of Pennsylvania.